-
Posted by
Two Blokes Jul 7 -
Filed in
Stock
-
5 views
Alphabet Inc's (NASDAQ:GOOG) Isomorphic Labs is preparing to begin human trials for drugs created using artificial intelligence, marking a potential breakthrough in pharmaceutical development. Founded in 2021 out of DeepMind's AlphaFold protein modelling system, Isomorphic blends AI expertise with pharmaceutical science to develop drugs faster and more accurately.
